|
|
 |
|
Viewing report
|
|
|
|
Opportunities and Challenges for Bioequivalent Generic Drugs in Brazil
Espicom Business Intelligence Ltd, April 2007, Pages: 190
An expanding market, a growing population, a regulatory regime supportive of the generics sector, robust domestic production and many untapped opportunities. Is Brazil the place for generic companies to be?
The world’s major emerging economies are attracting much investment and interest. Brazil is not least among them, and it is easy to see why with a population of 189 million and a GDP of US$978 billion in 2007.
But there are particular attractions for the producers of generic pharmaceuticals. For years the “generic” market was little more than a series of copycat products, similar to the branded product but not necessarily bioequivalent. Under increasing pressure from industry to respect patents, and with one eye on the need to cost effectively meet the growing health needs, the Brazilian authorities have led the way in the region in creating a market for truly bioequivalent generic drugs which now ranks in the top ten worldwide.
The generics market, already in a strong growth phase, is well placed to continue its future expansion. The generic production of oral contraceptives and endogenous hormones was approved in March 2007, a number of leading brands are due to lose their patent protection over the next 5 years and the use of generic drugs is expected to grow as price pressures bite.
But who are the leading players and what are their strengths? What barriers to market entry exist? What routes to market are favourable? What will be the operating and regulatory environment for companies? The answers to these and many other questions can be found in this new 200-page management report Opportunities and Challenges for Bioequivalent Generic Drugs in Brazil (Published April 2007).
Key areas addressed:
- 5-Year market forecast to 2012
- The generics market in context
- Review of the product registration procedure
- Pricing issues and reimbursement
- Political, legal and economic assessment
- Insightful review of 20 major domestic and foreign players in the market
- Detailed product registration data. Who produces what?
Includes much information not available in English elsewhere!
Customers who bought this item also bought
The World Generic Market Report 2008
Emerging Generic Drug Markets in Europe
Generic Drugs Market in Brazil (2007-2011)
Generic Strategies in Emerging Markets
Emerging Generic Drug Companies Worldwide 2007
Generic Handbook: A Guide to the Generic Drug Industry in the US, 2007 Edition
The Latin American Market for Generic Drugs - A Comparative Study of 7 Key Markets
GenericHandbook - A Guide to the Generic Drug Industry in the US
European Generic Drug Market Potential
Opportunities and Challenges for Generic Drugs in the UK 2007
Generic Series: An Introduction To The Canadian Generics Market - Key Trends And Leading Companies Shaping The Market
Booming US Generic Drug Market
|
|
|
|
